Today

Agents

Chat

Arena

Discover

More

App

Brainsway expands US insurance coverage for deep TMS treatment of OCD

BWAY•2026-10-26

Brainsway expanded US insurance coverage for deep TMS treatment of OCD.

1. Insurance coverage

Brainsway said it expanded US insurance coverage for deep TMS treatment of OCD.

Related News

CACI wins five-year U.S. Navy task order worth up to $281 million

CACI•2026-10-26

Braskem, creditors remain at odds over debt restructuring terms

BAK•2026-10-26

Nexentis subsidiary MitoCareX Bio completes initial AI drug screening with Boltz

•

2026-10-26

Daré Bioscience presents DARE-IDDS drug delivery device at PODD conference

DARE•2026-10-26

Roze AI Korea receives U.S. patent notice of allowance for evacuation route technology

RZAI•2026-10-26

Brainsway expands US insurance coverage for deep TMS treatment of OCD - BWAY News | Rallies